Moderna Vaccine New York Times

16 2020 healthday news moderna inc.

Moderna vaccine new york times. Coming just a week after similar news from pfizer and biontech the. Zimmer begins with the specific findings from the trail then goes on to address issues such as how this might help end the pandemic how moderna s results compare with pfizer s how long the vaccine offers protection and other questions related to the promise of vaccines to prevent infection with sars cov 2. New york based covaxx a subsidiary of united biomedical has created a vaccine containing parts of several viral proteins. Company and its german rival biontech plan to use rna as a messenger.

Comparatively moderna s vaccine costs about 15 to 25 per dose while pfizer s remains at 20 per dose. The us drugmaker announced on monday that its experimental vaccine has been found to be 94 5. On monday massachusetts based company moderna reported promising preliminary results from its coronavirus vaccine trial. Moderna s study reports that 95 trial subjects contracted covid 19.

The new york times reports that on monday researchers with moderna said early research indicates their vaccine could be 94 5 percent effective at preventing covid 19 infection. With half for the u s according to the new york times. Of those 5 people had received the vaccine and 90 had received a placebo. Tal zaks moderna s chief medical officer said in an interview.

The researchers behind the vaccine said the. If those trials go well some doses of a vaccine could become available for widespread use by the end of this year or early 2021 dr. Announced on monday that early results show its coronavirus vaccine is 94 5 percent effective. 11 they registered a phase 1 trial in taiwan.